414.52
price down icon0.66%   -2.76
pre-market  Pre-mercato:  416.90   2.38   +0.57%
loading

Idexx Laboratories Inc Borsa (IDXX) Ultime notizie

pulisher
02:27 AM

Vanguard Group Inc's Strategic Acquisition of IDEXX Laboratories Shares - GuruFocus.com

02:27 AM
pulisher
01:35 AM

IDEXX Laboratories' SWOT analysis: veterinary diagnostics leader faces market shifts - Investing.com

01:35 AM
pulisher
Nov 04, 2024

IDEXX Laboratories (NASDAQ:IDXX) Receives "Neutral" Rating from Piper Sandler - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

IDEXX Laboratories (NASDAQ:IDXX) Price Target Lowered to $481.00 at Barclays - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Robeco Institutional Asset Management B.V. Decreases Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

IDEXX stock falls 10% on Q3 revenue miss, lowered guidance - MSN

Nov 04, 2024
pulisher
Nov 03, 2024

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stake Reduced by New York State Common Retirement Fund - MarketBeat

Nov 03, 2024
pulisher
Nov 02, 2024

IDEXX Laboratories (WBO:IDXX) Enterprise Value : €32,027 Mil (As of Nov. 02, 2024) - GuruFocus.com

Nov 02, 2024
pulisher
Nov 02, 2024

IDEXX Laboratories (NASDAQ:IDXX) Releases Quarterly Earnings Results, Beats Expectations By $0.11 EPS - MarketBeat

Nov 02, 2024
pulisher
Nov 02, 2024

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 02, 2024
pulisher
Nov 01, 2024

Earnings call: IDEXX reports solid Q3 growth, revises full-year guidance - Investing.com Australia

Nov 01, 2024
pulisher
Nov 01, 2024

Here’s Why Aristotle Focus Growth Strategy Sold IDEXX Laboratories (IDXX) - Insider Monkey

Nov 01, 2024
pulisher
Nov 01, 2024

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock Position Reduced by AustralianSuper Pty Ltd - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

IDEXX Laboratories Inc (IDXX) Q3 2024 Earnings Call Highlights: Strong EPS Growth Amid Market ... - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

IDEXX Laboratories Inc (IDXX) Q3 2024 Earnings Call Highlights: Strong EPS Growth Amid Market Challenges - GuruFocus.com

Nov 01, 2024
pulisher
Nov 01, 2024

Idexx: Q3 Earnings Snapshot - The Advocate

Nov 01, 2024
pulisher
Nov 01, 2024

IDEXX Laboratories Reports Robust Q3 2024 Performance - TipRanks

Nov 01, 2024
pulisher
Oct 31, 2024

IDXXIdexx Laboratories Inc Latest Stock News & Market Updates - StockTitan

Oct 31, 2024
pulisher
Oct 31, 2024

IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Oct 31, 2024
pulisher
Oct 31, 2024

IDEXX Labs Q3 earnings top estimates, revenue falls short By Investing.com - Investing.com South Africa

Oct 31, 2024
pulisher
Oct 31, 2024

IDEXX Laboratories Announces Third Quarter Results - citybiz

Oct 31, 2024
pulisher
Oct 31, 2024

CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results - Business Wire

Oct 31, 2024
pulisher
Oct 31, 2024

IDEXX stock falls 10% on Q3 revenue miss, lowered guidance (NASDAQ:IDXX) - Seeking Alpha

Oct 31, 2024
pulisher
Oct 31, 2024

IDEXX laboratories cuts annual revenue forecast for third time as pet clinic visits slow - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

IDEXX Laboratories (NASDAQ:IDXX) Releases FY 2024 Earnings Guidance - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

IDEXX Adjusts Revenue Forecast As Pet Care Costs Bite - Finimize

Oct 31, 2024
pulisher
Oct 31, 2024

Calculating The Intrinsic Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

IDEXX Labs earnings beat by $0.11, revenue fell short of estimates - Investing.com India

Oct 31, 2024
pulisher
Oct 31, 2024

Idexx Laboratories (IDXX) Q3 Earnings Surpass Estimates - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

IDEXX Laboratories Q3 24 Earnings Conference Call At 8:30 AM ET - Nasdaq

Oct 31, 2024
pulisher
Oct 31, 2024

IDEXX Laboratories Q3 2024 Earnings: EPS at $2.80, Revenue Misses Estimates at $976 Million - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

IDEXX Labs Q3 earnings top estimates, revenue falls short - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

IDEXX Laboratories Inc Reveals Climb In Q3 Income, Beats Estimates - Nasdaq

Oct 31, 2024
pulisher
Oct 31, 2024

New York State Teachers Retirement System Cuts Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

IDEXX Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 31, 2024
pulisher
Oct 30, 2024

IDEXX Labs added as a new short idea at Hedgeye - MSN

Oct 30, 2024
pulisher
Oct 30, 2024

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch

Oct 30, 2024
pulisher
Oct 30, 2024

IDEXX Laboratories Q3 2024 Earnings Preview - MSN

Oct 30, 2024
pulisher
Oct 30, 2024

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Cuts Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day - MarketWatch

Oct 29, 2024
pulisher
Oct 29, 2024

abrdn plc Trims Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

Oct 29, 2024
pulisher
Oct 28, 2024

IDEXX Labs added as a new short idea at Hedgeye (NASDAQ:IDXX) - Seeking Alpha

Oct 28, 2024
pulisher
Oct 28, 2024

Investors Appear Satisfied With IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Prospects - Simply Wall St

Oct 28, 2024
pulisher
Oct 28, 2024

IDEXX Laboratories' Q3 2024 Earnings: What to Expect - MSN

Oct 28, 2024
pulisher
Oct 27, 2024

Forsta AP Fonden Buys 1,900 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

Oct 27, 2024
diagnostics_research IQV
$210.19
price up icon 0.49%
diagnostics_research MTD
$1,364.02
price up icon 1.63%
diagnostics_research A
$139.65
price up icon 2.03%
$153.49
price up icon 2.49%
diagnostics_research WAT
$387.34
price up icon 0.03%
Capitalizzazione:     |  Volume (24 ore):